Skip to content
Open access

De Novo Design and AlphaFold3 Evaluation of Protein Binders Targeting Specific Sites of MAP4K4

Sep 2026 · bioRxiv · 0 citations · 24 references
Biology

TL;DR

The results support that de novo design of small, site-specific protein probes for an underserved disease target is achievable using free, publicly available computational tools and minimal resources, pointing to a greater role for the public and amateur scientists to contribute to biotechnological advancement.

Read PDF

Similar papers

Aug 2026

Free energy perturbation and machine learning-assisted identification of potential MAP3K8 hit molecules: a comprehensive structure- and ligand-based studies.

The convergence of docking, dynamics, and free-energy results prioritized PM2, PM3, and PM4 as promising MAP3K8 hit candidates, which require further experimental validation and lead optimization.

M. Islam, A. Iqbal, M. A. Ali et al. · 0 citations
Sep 2026

Helical Peptidomimetic Inhibitors Targeting the Histone Chaperone ASF1 for Cancer Therapy

Targeting protein−protein interactions (PPIs) with shallow, extended interfaces remains challenging, as exemplified by the histone chaperone ASF1. Here, we report de novo designed d-sulfonyl-γ-AApeptide foldamers that mimic the hot-spot residues of the histone H3 C-terminal α-helix that are essential for ASF1 recogni...

Chao Hao, Xiao-Sa Wang, Kang Wang et al. · 0 citations
Open access Sep 2026

Structure-function analysis of PI3K signalling cascade base editing screens in cancer cells

Large-scale CRISPR base editing mutagenesis screens across 30 PI3K pathway proteins in three disease-relevant cancer cell models establish high-throughput base editing mutagenesis combined with structural analysis as a scalable strategy to delineate structure–function relationships and inform drug development.

Katrina McCarten, Bárbara Abreu, Benoit Baillif et al. · 0 citations
Open access Aug 2026

AI-enabled discovery and biochemical optimization of minibinders targeting cancer cell-surface proteins

This work presents a scalable mammalian cell-display workflow to identify AI-designed minibinders against cancer surface targets and identifies biochemical optimization beyond the binding interface as a critical requirement for translating AI-minibinders into functional applications.

B. Broske, B. McEnroe, S. C. Frechen et al. · 1 citation
Open access Aug 2026

First-in-class inhibitors of the protein lysine methyltransferase METTL21A.

A crystal structure of METTL21A is solved in complex with 6m, providing structural insight into ligand recognition and supporting further structure-guided optimization and establishing a biochemically and structurally validated starting point for probing METTL21A function and a foundation for the development of cellula...

Hugo Kocek, Michal Vaško, M. Dejmek et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.